Intelligent Bio Solutions Inc.
INBS | NASDAQ
$1.71
-$0.12 (-6.56%)
At close: Oct 30, 2026, 3:59 PM ET
$1.74
+$0.03 (+1.46%)
Pre-market:
Nov 2, 2026, 7:36 AM ET
-6.56%
(1D)No price chart data available for 1D timeframe.
Rating
39
+4.5 ptsFundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #558/1028 (Top 54%)
Key Statistics
Market Data
Market Cap $5.67M
1D Range
1.69 1.77
52W Range
1.44 17.92
Valuation (TTM)
PE -0.18
PB 1.03
EV/EBITDA -0.30
Valuation (NTM)
Forward PE 1.17
Forward PEG -0.00
Price Target $0.00
Cash Flow
FCF Yield -215.2%
SBC Adj. FCF Yield -218.2%
SBC Impact -1.4%
Margins
Gross Margin 27.7%
Operating Margin -305.0%
FCF Margin -289.5%
Growth (CAGR)
Revenue 3Y | 5Y 49.7% |
19.9%
Dil EPS 3Y | 5Y 121.3% |
53.3%
FCF 3Y | 5Y -11.3% |
-21.8%
Returns
ROA -104.1%
ROE -170.4%
ROIC -179.6%
Financial Health
Net Cash
$2.17M
Current Ratio 1.44
Interest Coverage -190.05
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Intelligent Bio Solutions Inc. operates as a life sciences firm focused on developing non-invasive, real-time monitoring and diagnostic solutions for both patients and their primary healthcare provide...
Sector Healthcare
Industry Medical - Devices
Employees 59
IPO Date Dec 23, 2020
Website ibs.inc
Fiscal Year July - June
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove INBS